Evidence map›Paper›PMID 41854614›Full record

ArticleJAMA network open2026

Use and Implications of the Fracture Risk Assessment Tool in Primary Hyperparathyroidism.

Vivek R Sant, Yaser ElNakieb, Justin F Rousseau, Yu-Lun Liu, Craig D Rubin, Naim M Maalouf

Abstract read
In one paragraph

Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vivek R SantSection of Endocrine Surgery, Department of Surgery, UT Southwestern Medical Center, Dallas.
Yaser ElNakiebClinical Informatics Center, UT Southwestern Medical Center, Dallas.
Justin F RousseauDepartment of Neurology, UT Southwestern Medical Center, Dallas.
Yu-Lun LiuPeter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas.
Craig D RubinDivision of Geriatric Medicine, Department of Medicine, UT Southwestern Medical Center, Dallas.
Naim M MaaloufDepartment of Internal Medicine and Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, UT Southwestern Medical Center, Dallas.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Although primary hyperparathyroidism (PHPT) increases the risk of osteoporotic fractures, estimation of fracture probability among patients with PHPT remains challenging. Use of the Fracture Risk Assessment Tool (FRAX) among these patients remains poorly characterized, and its utility in identifying patients who may experience fracture risk reduction following parathyroidectomy (PTX) remains unknown. Objective: To examine the calibration of FRAX in adults with PHPT and to describe the association between estimated probability and differential fracture risk with PTX compared with nonsurgical management. Design, Setting, and Participants: This retrospective cohort study was performed from January 1, 2000, to January 1, 2024, using the TriNetX electronic health record US dataset. Participants included adults aged 40 to 90 years with diagnosis or biochemistry findings consistent with PHPT, excluding those with missing or out-of-range FRAX parameters. Exposures: PTX vs nonsurgical management. Main Outcomes and Measures: Observed major osteoporotic fracture (MOF) and hip fracture. Ten-year FRAX estimations of fracture probability were calculated without bone mineral density (BMD) findings. Results: Among 59 194 patients with PHPT (mean [SD] age, 65.9 [10.8] years; 44 540 [75.2%] female), 14 783 (25.0%) were treated with PTX. Observed MOF and hip fractures were slightly greater than estimated by FRAX for all deciles of risk, with an MOF calibration y-intercept of 2.0% and slope of 1.17 and hip fracture calibration y-intercept of 1.4% and slope of 1.02. Overall, PTX was associated with a 12% decrease in MOF (hazard ratio [HR], 0.88; 95% CI, 0.77-1.02) and a 13% decrease in hip fracture (HR, 0.87; 95% CI, 0.72-1.07). The MOF score above which PTX was associated with consistently lower MOF hazard was 1.2%, and the corresponding hip score above which PTX was associated with consistently lower hip fracture hazard was 2.7%. Of the cohort not meeting traditional guideline-based surgical criteria, 6522 (25.0%) met this hip score for consistent fracture reduction associated with PTX. Conclusions and Relevance: In this cohort study of US patients with PHPT, FRAX estimation exhibited acceptable performance. FRAX may effectively stratify fracture risk and inform surgical decision-making even in absence of BMD. A larger subset of patients than previously identified by guidelines may benefit from parathyroidectomy from the standpoint of fracture prevention.

Indexed as

Hip FracturesHyperparathyroidism, PrimaryOsteoporotic FracturesAdultAgedAged, 80 and overBone DensityFemaleHumansMaleMiddle AgedParathyroidectomyRetrospective StudiesRisk Assessment

Identifiers

PMID41854614
PMCPMC13003369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.